TABLE 1.
Baseline characteristics of the remdesivir cohort
| Baseline characteristics a | n = 57 |
|---|---|
| Age b | 44 (31‐51) |
| Age group in years | |
| <18 | 2 (3.5) |
| 18‐50 | 39 (68) |
| 50‐65 | 14 (25) |
| >65 | 2 (3.5) |
| Sex | |
| Male | 47 (82) |
| Female | 10 (18) |
| Blood group distribution | |
| A | 10 (18) |
| B | 22 (38.5) |
| O | 22 (38.5) |
| AB | 3 (5) |
| Type of transplant | |
| LRKT | 20 (34) |
| SKT | 14 (24.5) |
| KPD | 9 (16) |
| DKT | 14 (24.5) |
| Time from transplant to COVID‐19 | |
| <1 year | 15 (26) |
| >1 year | 42 (74) |
| Comorbidities | |
| Hypertension | 39 (68) |
| Diabetes | 10 (17) |
| Heart disease | 2 (3.5) |
| Obesity | 21 (37) |
| Others | 8 (14) |
| Baseline immunosuppression | |
| Triple regimen | 48 (82) |
| Dual regimen | 10 (18) |
| Radiological abnormalities on admission | |
| Yes | 57(100) |
| No | 0 (0) |
| COVID‐19 severity on hospital admission | |
| Moderate | 34 (59) |
| Severe | 23 (41) |
| Days from admission to RDV initiation | |
| 0 | 32 (56) |
| 1‐2 | 21 (37) |
| 3‐4 | 2 (3.5) |
| >5 | 2 (3.5) |
| Modified WHO Ordinal scale on RDV initiation c | |
| 3 | 11 (19) |
| 4 | 21 (37) |
| 5 | 25 (44) |
| 6 | 0 (0) |
| Days from onset of symptoms to RDV initiation b | 6 (5‐7) |
| Remdesivir course | |
| 5 days | 18 (31) |
| 10 days | 39 (69) |
Abbreviations: DKT, deceased donor transplant; KPD, kidney paired donation; LRKT, living related kidney transplant; SKT, spousal kidney donation.
a
Data expressed as numbers(percentage).
b
Data expressed as median(interquartile range).
c
The 7‐point modified WHO ordinal scale used was as follows: (7) Death, (6) KTR on invasive mechanical ventilation, (5) KTR on noninvasive ventilation or high flow oxygen devices, (4) KTR on supplemental oxygen, (3) hospitalized KTR but on room air, (2) not hospitalized, limitation on activities, (1) not hospitalized, no limitations on activities.